Directorate Change

RNS Number : 2209U
Accrol Group Holdings PLC
11 July 2018
 

11 July 2018

Accrol Group Holdings plc

("Accrol")

AIM: ACRL

 

DIRECTORATE CHANGE

 

Accrol, the leading independent tissue converter in the UK, announces that, following the appointment of Steve Townsley as Chief Financial Officer on 11 June 2018, Martin Leitch has now stepped down from the Board.

 

Martin was appointed to the Board as Interim CFO in February 2018 to assist in the early stages of the business turnaround and to allow a search for a permanent CFO to be conducted in an orderly fashion. He will remain with the business for a short period to complete an effective handover.

 

Dan Wright, Executive Chairman of Accrol, said: "On behalf of the Board, I extend our thanks to Martin for his considerable support and help in progressing the turnaround of the business."

 

Enquiries:

Accrol Group Holdings plc

Tel: +44 (0) 1254 278 844

Dan Wright, Executive Chairman

 

Gareth Jenkins, Chief Executive Officer

 

Steve Townsley, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker)

 

Dan Bate / Andrew Jones                                                                  

Tel: +44 (0) 161 831 1512

Dominic King / John Goold                                                                     

Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited                                    

Tel: +44 (0) 203 567 0510

Cat Valentine (cvalentine@belvederepr.com)

 

Llewellyn Angus (langus@belvederepr.com)

 

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. 

 

Accrol operates from three sites:

 

·      A manufacturing, storage and distribution facility in Blackburn;

·      A facial tissue plant, also in Blackburn; and

·      A manufacturing, storage and distribution facility in Leyland.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLGDRDGBBGIG
UK 100